Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines
Mario Niepel1*, Marc Hafner1*, Emily A. Pace2*, Mirra Chung1, Diana H. Chai2, Lili Zhou1, Birgit Schoeberl2 and Peter K. Sorger1
1 HMS LINCS Center, Harvard Medical School, Boston, MA; 2 Merrimack Pharmaceuticals, Cambridge, MA
Sci Signal (2013) 6, ra84.
doi:10.1126/scisignal.2004379 /
PMID:24065145 /
PMCID:PMC3845839
Overview
This browser widget serves to explore the basal levels and activity of key receptor tyrosine kinases (RTKs) across the panel of 39 breast cancer cell lines studied in Niepel et al. (2013). The set of measurements comprises the abundance and basal phosphorylation of 22 receptors and 3 downstream kinases (ERK, Akt, and Src). Hovering the cursor over the names in the Selection Panel gives a rapid scan over the available data; clicking on a name fixes the choice. (For more info, click on the ⓘ icon.)